International Stem Cell (ISCO) Net Margin Growth (3y) (2013 - 2026)
International Stem Cell (ISCO) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - | -5,319.00 |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | -1,665.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,672.00 |
| Dec 31, 2025 | -1,600.00 |
| Sep 30, 2025 | 2,137.00 |
| Jun 30, 2025 | -1,829.00 |
| Mar 31, 2025 | -4,347.00 |
| Dec 31, 2024 | 1,970.00 |
| Sep 30, 2024 | 4,513.00 |
| Jun 30, 2024 | 5,181.00 |
| Mar 31, 2024 | 3,585.00 |
| Dec 31, 2023 | 3,435.00 |
| Sep 30, 2023 | 8,094.00 |
| Jun 30, 2023 | 8,984.00 |
| Mar 31, 2023 | 1,884.00 |
| Dec 31, 2022 | 10,221.00 |
| Sep 30, 2022 | -2,028.00 |
| Jun 30, 2022 | 2,782.00 |
| Mar 31, 2022 | 4,040.00 |
| Dec 31, 2021 | 2,704.00 |
| Sep 30, 2021 | -5,466.00 |
| Jun 30, 2021 | -3,619.00 |